India’s startup funding market is producing three very different stories this week. Superhealth is changing the investor mix of its planned hospital-expansion round. Online pharmacy PlatinumRx is reportedly in talks for a large fundraise. And entrepreneur Manav Garg is preparing a new artificial-intelligence commerce venture with possible backing from Sachin Bansal.

The important detail is that not all three deals are complete. Superhealth has partial commitments, while PlatinumRx and Garg’s new venture are still in discussions.

Superhealth replaces Ronnie Screwvala with TechU Ventures

Bengaluru-based Superhealth was founded in 2024 by Varun Dubey. The company is building a hospital network based on fixed prices for medical procedures and a zero-commission model for doctors.

This means a patient should know the procedure cost upfront instead of facing a bill that changes through multiple add-ons. Superhealth also uses its in-house SuperOS platform to manage tasks ranging from consultations and diagnostics to surgery scheduling and discharge.

The startup’s proposed Rs. 100 crore fundraise has changed direction. Ronnie Screwvala is no longer participating after the two sides reportedly failed to agree on terms. US-based TechU Ventures and high-net-worth individuals have committed around Rs. 50 crore so far, while Superhealth continues talks for the remaining amount as per Moneycontrol reports.

The funding, if fully closed, would support Superhealth’s hospital-network expansion. Its competitors include Apollo Hospitals, Narayana Health, Manipal Hospitals and newer healthcare providers trying to make treatment pricing more transparent.

PlatinumRx discusses a $32 million round

PlatinumRx is an online pharmacy founded in 2023 by Ashutosh Pandey and Piyush Kumar. Its focus is affordable medicine delivery, especially by helping customers find lower-cost substitutes where appropriate.

The Bengaluru-based company is reportedly in talks to raise about $32 million, or more than Rs. 300 crore, in a round led by Sofina. The proposed deal could value PlatinumRx between $150 million and $200 million, according to Inc42.

However, this is not a closed funding announcement. The investors, valuation and final deal size could change before the transaction is completed.

PlatinumRx previously raised $6 million in Series A funding in 2025. That funding was intended for supply-chain strengthening, fulfilment expansion and product development. Its current aim remains the same: make quality medicines easier to access at lower prices. Company says it operates licensed pharmacy premises and delivers across India.

The company competes with Tata 1mg, PharmEasy, Netmeds, Apollo 24|7 and fellow affordable-medicine platform Plazza. In this category, customer trust, prescription compliance and dependable delivery are just as important as discounts.

Manav Garg’s agentic commerce startup

Manav Garg, who recently stepped down as executive chairman of Emergent, is reportedly launching an agentic commerce startup. Sachin Bansal, the co-founder of Flipkart and Navi, is said to be discussing an investment of $20 million to $30 million.

The startup has not yet been formally announced, and its product details remain limited. Sources told Moneycontrol that Garg is seeking a much larger initial round of around $100 million.

Agentic commerce means using AI software that can help users find, compare and possibly buy products. For example, instead of opening five shopping apps, a user might ask an AI assistant to find a phone within a budget, compare offers and guide the purchase.

This emerging space will face competition from Amazon, Google, OpenAI-powered shopping tools and established ecommerce platforms. The challenge will be building consumer trust, reliable product data and safe payment experiences.